Evidence map›Paper›PMID 29637888›Full record

SynthesisEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018

The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.

Christina Greenaway, Manish Pareek, Claire-Nour Abou Chakra, Moneeza Walji, Iuliia Makarenko, Balqis Alabdulkarim, Catherine Hogan, Ted McConnell, Brittany Scarfo, Robin Christensen and 8 more

Open access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Cost-effectiveness of active tuberculosis screening among high-risk populations in low tuberculosis incidence countries: a systematic review, 2008 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Pooled it
  4. Guideline
  5. Trial
  6. Article
  7. Screening and treatment practices for tuberculosis infection in Nordic, Baltic and Central European countries and Ukraine in 2023.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region.The European journal of health economics : HEPAC : health economics in prevention and care · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Migration and tuberculosis in Europe.Journal of clinical tuberculosis and other mycobacterial diseases · 2020
    Article
  17. Review
  18. Article
  19. Building a European database to gather multi-country evidence on active and latent TB screening for migrants.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 6 countries.

Christina GreenawayDivision of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, Canada.
Manish PareekDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
Claire-Nour Abou ChakraDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Québec, Canada.
Moneeza WaljiCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Iuliia MakarenkoCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Balqis AlabdulkarimCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Catherine HoganDivision of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, Canada.
Ted McConnellCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Brittany ScarfoCentre for Clinical Epidemiology of the Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada.
Robin ChristensenMusculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Anh TranNational Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Sydney, Australia.
Nick RowbothamNational Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Sydney, Australia.
Teymur NooriEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Marieke J van der WerfEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Kevin PottieC.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute, Ottawa, Ontario, Canada.
Alberto MatteelliClinic of Infectious and Tropical Diseases, University of Brescia and Brescia Spedali Civili General Hospital, World Health Organization Collaborating Centre for TB/HIV and TB Elimination, Brescia, Italy.
Dominik ZennerRespiratory Diseases Department, Centre for Infectious Disease Surveillance and Control (CIDSC), Public Health England, London, United Kingdom.
Rachael L MortonNational Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Sydney, Australia.
Jewish General Hospital · CAEuropean Centre for Disease Prevention and Control · SEUniversity of Sydney · AUBruyère · CAFrederiksberg Hospital · DKMcGill University · CANational Health and Medical Research Council · AUUniversité de Sherbrooke · CAUniversity College London · GBUniversity of Brescia · ITUniversity of Leicester · GB

Funding

Department of Health PDF-2015-08-102
6 · The paper itself

Abstract

backgroundThe foreign-born population make up an increasing and large proportion of tuberculosis (TB) cases in European Union/European Economic Area (EU/EEA) low-incidence countries and challenge TB elimination efforts.

Indexed as

Emigrants and ImmigrantsRefugeesCost-Benefit AnalysisEuropeEuropean UnionHumansMass ScreeningTransients and MigrantsTuberculosisactive tuberculosisEU/EEAmigrantsscreening

Identifiers

PMID29637888
PMCPMC5894252
OpenAlexW2796148552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.